Content Spotlight
Podcast: Sustainability equals efficiency, says eXmoor
eXmoor Pharma discusses the steps taken to build a more sustainable facility, the importance of its design, and calls for industry to share advice and initiatives.
Latest News
thumbnail
Deal-MakingHalozyme’s $2.1bn Evotec bid: First the ins, now the out
Halozyme’s $2.1bn Evotec bid: First the ins, now the out
The proposed acquisition of Evotec, which would have transformed Halozyme from a therapeutics-based drug delivery platform into a full bioprocess services company, has been withdrawn.
Deal-Making
Halozyme’s $2.1bn Evotec bid: First the ins, now the outHalozyme’s $2.1bn Evotec bid: First the ins, now the out
The proposed acquisition of Evotec, which would have transformed Halozyme from a therapeutics-based drug delivery platform into a full bioprocess services company, has been withdrawn.
Deal-Making
CDMO success stories: News from Lonza, Samsung Bio, FujifilmCDMO success stories: News from Lonza, Samsung Bio, Fujifilm
Fujifilm Diosynth expands a cell therapy facility in California, Lonza produces first GMP batches from New Hampshire plant, and Samsung Biologics signs $688 million seven-year contract. Welcome to our big CDMO round-up.
Facilities & Capacity
CHOP teams with INCA to bring CAR-T therapies to children in BrazilCHOP teams with INCA to bring CAR-T therapies to children in Brazil
The organizations have built a CAR-T cell production center in Rio de Janeiro, Brazil with help from a $4 million government grant.
Facilities & Capacity
The biotechnology vendor will use the facility to offer process development, optimization, and validation services.
Global Markets
The plant will manufacture filtration products to meet the growing demands for advanced therapies, the firm said.
Webcasts
Talent dearth continues to puzzle life sciences industry, says recruitment expertTalent dearth continues to puzzle life sciences, says recruitment expert
Andrew Mears, CEO of Lead Candidate, highlighted a dichotomy in the industry, where some sectors are downsizing while others are experiencing rapid growth during a video interview at Biotech Week Boston (BWB).
Regulations
IRA matches BIOSECURE in driving CDMO sector in IndiaIRA matches BIOSECURE in driving CDMO sector in India
While much talk at CPHI Milan centered on the potential impact of BIOSECURE, other US policies – particularly the Inflation Reduction Act (IRA) – are proving a boon for Indian CDMOs.
Facilities & Capacity
Aurigene’s chief commercial officer says his firm and other Indian CDMOs are “a very viable alternative” if major Chinese manufacturers are removed from the US biopharma supply chain.
Therapeutic Class
CHOP teams with INCA to bring CAR-T therapies to children in BrazilCHOP teams with INCA to bring CAR-T therapies to children in Brazil
The organizations have built a CAR-T cell production center in Rio de Janeiro, Brazil with help from a $4 million government grant.
Facilities & Capacity
CGT Catapult releases report on UK advanced therapy developmentsCGT Catapult releases report on UK advanced therapy developments
A survey of 32 UK-based companies shows that the GMP infrastructure for cell and gene therapies (CGTs) has grown in the country but facility utilization has declined on last year.
Upstream & Downstream Processing
The guide is designed to embolden fast development of life-saving antibody therapies.
Facilities & Capacity
Lonza doubles bioconjugation capacity at Swiss facilityLonza doubles bioconjugation capacity at Swiss facility
The contract development manufacturing organization (CDMO) is adding two 1,200-L production suites at its Ibex biopark facility in Visp, Switzerland.